FIELD: medicine, pharmaceutics.
SUBSTANCE: disclosed are pharmaceutical antibacterial composition and methods of treatment or prevention of bacterial infections by its application or by application of combination of its ingredients (versions). Pharmaceutical composition contains pharmaceutically effective quantity of: (a) sulbactam or its pharmaceutically acceptable salt and (b) beta-lactamase inhibitor trans-7-oxo-6-(sulphoxy)-1,6-diazabicyclo-[3.2.1]-octane-2-carboxamide or its pharmaceutically acceptable salt.
EFFECT: increase of antibacterial activity of claimed combination (synergism) against strains, which produce beta-lactamases of extended spectrum.
15 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITIONS CONTAINING BETA-LACTAM ANTIBIOTIC, SULBACTAM AND BETA-LACTAMASE INHIBITOR | 2011 |
|
RU2569059C2 |
1,6-DIAZABICYCLO [3,2,1] OCTANE-7-ONA DERIVATIVES AND USE THEREOF FOR TREATING BACTERIAL INFECTIONS | 2013 |
|
RU2614418C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIBACTERIAL AGENTS | 2014 |
|
RU2702361C2 |
1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONА DERIVATIVES AND USING THEM IN TREATING BACTERIAL INFECTIONS | 2012 |
|
RU2570423C2 |
NITROGEN-CONTAINING COMPOUNDS AND APPLICATION THEREOF | 2012 |
|
RU2569307C1 |
PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIBACTERIAL AGENTS | 2015 |
|
RU2705375C2 |
1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONE DERIVATIVES AND USING THEM FOR TREATING BACTERIAL INFECTIONS | 2012 |
|
RU2578370C2 |
BETA-LACTAMASE INHIBITORS | 2009 |
|
RU2445314C9 |
1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONE DERIVATIVES AND THEIR APPLICATION FOR BACTERIAL INFECTIONS TREATMENT | 2012 |
|
RU2636147C1 |
POLYMORPHOUS AND PSEUDOPOLYMORPHOUS FORMS OF THE PHARMACEUTICAL COMPOUND | 2010 |
|
RU2727509C2 |
Authors
Dates
2015-08-20—Published
2011-10-04—Filed